background: available drugs are not able to eradicate intracellular viral dna in patients with hepatitis b virus (hbv) infections. hbsag vaccine could induce immunity and subsequently eradicate hepatitis b virus in proportions of these patients. our aim was to evaluate the efficacy of hbsag as a mode of therapy in inactive carriers. materials and methods: forty two consecutive patients of inact...

conclusions it is concluded that most hbeag negative hepatitis b patients with serum hbv dna level of 2000-20000 iu/ml, persistent normal alt concentration, and no or mild liver damage on biopsy can be clinically managed as hbv inactive carriers. results two hundred forty-three hbeag negative hepatitis b patients were stratified into three groups based on to their hbv dna level including group ...

background: we aimed to explore whether maternal asymptomatic hepatitis b (hb) infection effects on pre-term rupture of membranous (prom), stillbirth, preeclampsia, eclampsia, gestational hypertension, or antepartum hemorrhage. methods: we searched the pubmed, scopus, and isi web of science from 1990 to feb 2015. in addition, electronic literature searches supplemented by searching the gray lit...

background influenza can causes morbidity and mortality that are greatly enhanced in patients with underlying chronic diseases such as cirrhotic patients. this study was performed to assess the immunogenicity of influenza vaccination in patients with cirrhosis and inactive carriers of hepatitis b virus infection. methods in this clinical study 93 enrolled subjects divided into 3 groups: cirrhot...

background: with respect to the importance of hepatitis a in patients with chronic liver disease, current study was conducted with the aim of determining the prevalence of previous hepatitis a infection in hepatitis b virus carriers with different stages of liver disease. materials and methods: this was a cross sectional study. 283 hbsag positive subjects (including 118 inactive carriers, 144 p...

BACKGROUND Oxidative stress can be defined as an increase in oxidants and/or a decrease in antioxidant capacity. There is limited information about the oxidative status in subjects with hepatitis B virus infection. We aimed to evaluate the oxidative status in patients with various clinical forms of chronic hepatitis B infection. METHODS Seventy-six patients with hepatitis B virus infection, i...

PURPOSE Hepatitis B viral markers may be useful for predicting outcomes such as liver-related deaths or development of hepatocellular carcinoma. We determined the frequency of these markers in different clinical stages of chronic hepatitis B infection. METHODS We compared baseline hepatitis B viral markers in 317 patients who were enrolled in a prospective study and identified the frequency o...